Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00099697 · ClinicalTrials.gov registry record · NA

Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans

A NA study of Obesity and Aging, sponsored by National Institute on Aging (NIA).

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT00099697 is a NA study of Obesity and Aging that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00099697, a NA study of Obesity and Aging, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether DHEA replacement therapy decreases abdominal fat and improves insulin sensitivity.

Interventions

  • DRUG DHEA

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2001-06
Est. Completion 2004-02
Phase NA

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT00099697

The ClinicalTrials.gov registry entry for NCT00099697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which DHEA is the first listed.

NCT00099697 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00099697 about?

NCT00099697 is a clinical study titled "Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans". The purpose of this study is to determine whether DHEA replacement therapy decreases abdominal fat and improves insulin sensitivity.

What is the current status of trial NCT00099697?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2001-06. Estimated completion is 2004-02.

What conditions does trial NCT00099697 study?

This clinical trial studies the following conditions: Obesity, Aging, Insulin Resistance.

What interventions are being tested in trial NCT00099697?

The interventions under investigation include: DHEA (DRUG).

Who is sponsoring clinical trial NCT00099697?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00099697 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.